查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1331119

器官晶片的全球市場

Organs-on-Chips
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球器官晶片市場將達到 4973 億美元

隨著後COVID-19商業環境的變化，全球晶片器官市場預計2022年為443億美元，到2030年將修正為4973億美元。預計複合年複合成長率為35.3%超過肝臟是本報告分析的細分市場之一，預計複合年成長率為 36.7%，到分析期結束時將達到 1,863 億美元。鑑於大流行後的持續復甦，未來八年腎臟細分市場的年複合成長率已調整為 37.4%。

美國市場預計將成長 134 億美元，中國市場年複合成長率為 33.5%

到 2022 年，美國器官晶片市場預計將達到 134 億美元。作為世界第二大經濟體，中國在2022年至2030年的分析期間預計將以33.5%的年複合成長率成長，預計到2030年市場規模將達到799億美元。其他值得注意的地域市場包括日本和加拿大，預計 2022 年至 2030 年將分別成長 32% 和 30.1%。在歐洲，德國的年複合成長率預計約為 24.5%。

受訪企業示例

  • Ascendance Biotechnology, Inc.
  • AxoSim, Inc.
  • CN Bio Innovations Ltd.
  • Emulate, Inc.
  • Hurel Corporation
  • InSphero AG
  • Kirkstall Ltd.
  • Mimetas
  • Nortis, Inc.
  • SynVivo
  • TissUse GmbH

目錄

第1章 調查方法

第2章 執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 競爭

簡介目錄
Product Code: MCP13775

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Organs-on-Chips Market to Reach $497.3 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Organs-on-Chips estimated at US$44.3 Billion in the year 2022, is projected to reach a revised size of US$497.3 Billion by 2030, growing at aCAGR of 35.3% over the period 2022-2030. Liver, one of the segments analyzed in the report, is projected to record 36.7% CAGR and reach US$186.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Kidney segment is readjusted to a revised 37.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $13.4 Billion, While China is Forecast to Grow at 33.5% CAGR

The Organs-on-Chips market in the U.S. is estimated at US$13.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$79.9 Billion by the year 2030 trailing a CAGR of 33.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 32% and 30.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 24.5% CAGR.

Select Competitors (Total 12 Featured) -

  • Ascendance Biotechnology, Inc.
  • AxoSim, Inc.
  • CN Bio Innovations Ltd.
  • Emulate, Inc.
  • Hurel Corporation
  • InSphero AG
  • Kirkstall Ltd.
  • Mimetas
  • Nortis, Inc.
  • SynVivo
  • TissUse GmbH

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Organs-on-Chips - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Organs-on-Chips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Organs-on-Chips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Kidney by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Kidney by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 17: World Organs-on-Chips Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 19: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 21: World 8-Year Perspective for Cosmetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 23: USA 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 25: USA 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Canada 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Canada 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • JAPAN
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 31: Japan 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Japan 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • CHINA
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 34: China Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 35: China 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
    • TABLE 36: China Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 37: China 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • EUROPE
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 39: Europe 8-Year Perspective for Organs-on-Chips by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 41: Europe 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 43: Europe 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • FRANCE
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 44: France Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: France 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
    • TABLE 46: France Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 47: France 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • GERMANY
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 48: Germany Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Germany 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Germany 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • ITALY
    • TABLE 52: Italy Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Italy 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
    • TABLE 54: Italy Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 55: Italy 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • UNITED KINGDOM
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 56: UK Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: UK 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
    • TABLE 58: UK Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 59: UK 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 61: Rest of Europe 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
    • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Rest of Europe 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Asia-Pacific 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
    • TABLE 66: Asia-Pacific Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Asia-Pacific 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Rest of World 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
    • TABLE 70: Rest of World Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Rest of World 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030

IV. COMPETITION